Xbrane Biopharma AB (XBRANE) - Financial Analysis Review Summary Xbrane Biopharma AB (Xbrane), formerly known as Xbrane Bioscience AB, is a biopharmaceutical company that develops and manufactures complex generics. The company's product portfolio includes biosimilars and generic drugs developed for people suffering from critical diseases. It combines its proprietary microsphere and protein production technology platforms to develop and produce generics drugs for controlled release of the activ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.